Fondazione Telethon

Fondazione Telethon company information, Employees & Contact Information

Founded in 1990, Telethon Italy is one of the biggest biomedical charity in Italy, whose mission is to advance biomedical research towards the diagnosis, cure and prevention of muscular dystrophies and other human genetic diseases. Telethon Italy focuses on scientific research and does not offer healthcare, material assistance to patients and families or advocacy. Since 1991, Telethon Italy has invested 394 million Euros in research and funded 2,477 research projects on more than 445 human genetic diseases, which range from basic research to clinical trials.

Company Details

Employees
320
Founded
-
Address
Via Varese 16 B, Roma,italy 00185,italy
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
Roma, Italy
Looking for a particular Fondazione Telethon employee's phone or email?

Fondazione Telethon Questions

News

How Newborn Liver Cells Shape Growth and Future Treatments - Ricerca Malattie Genetiche Rare

How Newborn Liver Cells Shape Growth and Future Treatments Ricerca Malattie Genetiche Rare

A platform dedicated to Duchenne Muscular Dystrophy - Ricerca Malattie Genetiche Rare

A platform dedicated to Duchenne Muscular Dystrophy Ricerca Malattie Genetiche Rare

Research, innovation and global success: EsoBiotec takes off also thanks to Italian science - Ricerca Malattie Genetiche Rare

Research, innovation and global success: EsoBiotec takes off also thanks to Italian science Ricerca Malattie Genetiche Rare

MAA for the Gene Therapy for the treatment of Wiskott-Aldrich Syndrome submitted to EMA - Ricerca Malattie Genetiche Rare

MAA for the Gene Therapy for the treatment of Wiskott-Aldrich Syndrome submitted to EMA Ricerca Malattie Genetiche Rare

Orchard Therapeutics Receives EC Approval for the Treatment of Early-Onset MLD - Ricerca Malattie Genetiche Rare

Orchard Therapeutics Receives EC Approval for the Treatment of Early-Onset MLD Ricerca Malattie Genetiche Rare

Joint Call for Applications Fondazione Cariplo e Fondazione Telethon 2023 - Ricerca Malattie Genetiche Rare

Joint Call for Applications Fondazione Cariplo e Fondazione Telethon 2023 Ricerca Malattie Genetiche Rare

Strimvelis receives European marketing authorisation to treat ADA-SCID - Ricerca Malattie Genetiche Rare

Strimvelis receives European marketing authorisation to treat ADA-SCID Ricerca Malattie Genetiche Rare

From psoriasis to Lowe syndrome: clinical trial kicks off thanks to collaboration with Can-Fite - Ricerca Malattie Genetiche Rare

From psoriasis to Lowe syndrome: clinical trial kicks off thanks to collaboration with Can-Fite Ricerca Malattie Genetiche Rare

Gene therapy targeted to the brain: a complex but not impossible challenge - Ricerca Malattie Genetiche Rare

Gene therapy targeted to the brain: a complex but not impossible challenge Ricerca Malattie Genetiche Rare

Violet’s story: between research and outreach - Ricerca Malattie Genetiche Rare

Violet’s story: between research and outreach Ricerca Malattie Genetiche Rare

Gene therapy: target liver - Ricerca Malattie Genetiche Rare

Gene therapy: target liver Ricerca Malattie Genetiche Rare

The Armenise-Harvard Foundation invests one million dollars in brain research - Ricerca Malattie Genetiche Rare

The Armenise-Harvard Foundation invests one million dollars in brain research Ricerca Malattie Genetiche Rare

Clinical Evidence Confirms Timing as Crucial in Gene Therapy for MLD - Ricerca Malattie Genetiche Rare

Clinical Evidence Confirms Timing as Crucial in Gene Therapy for MLD Ricerca Malattie Genetiche Rare

Telethon multi-round Call for research projects 2021 – 2024 Round 2 - Ricerca Malattie Genetiche Rare

Telethon multi-round Call for research projects 2021 – 2024 Round 2 Ricerca Malattie Genetiche Rare

Potential adverse reaction to gene therapy in a patient treated with Strimvelis for the treatment of ADA-SCID - Ricerca Malattie Genetiche Rare

Potential adverse reaction to gene therapy in a patient treated with Strimvelis for the treatment of ADA-SCID Ricerca Malattie Genetiche Rare

Aicardi-Goutières syndrome: when the immune system detects viruses where there are none - Ricerca Malattie Genetiche Rare

Aicardi-Goutières syndrome: when the immune system detects viruses where there are none Ricerca Malattie Genetiche Rare

Fondazione Telethon announces commitment to make gene therapy for Wikott-Aldrich Syndrome available to patients - Ricerca Malattie Genetiche Rare

Fondazione Telethon announces commitment to make gene therapy for Wikott-Aldrich Syndrome available to patients Ricerca Malattie Genetiche Rare

Naples, world’s first gene therapy for a rare retinal disease - Ricerca Malattie Genetiche Rare

Naples, world’s first gene therapy for a rare retinal disease Ricerca Malattie Genetiche Rare

Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe - Ricerca Malattie Genetiche Rare

Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe Ricerca Malattie Genetiche Rare

ERC Funding to three young researchers from Fondazione Telethon Institutes - Ricerca Malattie Genetiche Rare

ERC Funding to three young researchers from Fondazione Telethon Institutes Ricerca Malattie Genetiche Rare

Ilaria Villa new Managing Director of Fondazione Telethon - Ricerca Malattie Genetiche Rare

Ilaria Villa new Managing Director of Fondazione Telethon Ricerca Malattie Genetiche Rare

Beta Thalassemia: clinical trial provides encouraging evidence for efficacy of gene therapy - Ricerca Malattie Genetiche Rare

Beta Thalassemia: clinical trial provides encouraging evidence for efficacy of gene therapy Ricerca Malattie Genetiche Rare

Alberto Auricchio appointed as director at TIGEM - Ricerca Malattie Genetiche Rare

Alberto Auricchio appointed as director at TIGEM Ricerca Malattie Genetiche Rare

Discovery of a novel drug candidate to develop effective treatments for brain disorders - Ricerca Malattie Genetiche Rare

Discovery of a novel drug candidate to develop effective treatments for brain disorders Ricerca Malattie Genetiche Rare

Study of genetic condition leads to discovery of mechanism that promotes cance development - Ricerca Malattie Genetiche Rare

Study of genetic condition leads to discovery of mechanism that promotes cance development Ricerca Malattie Genetiche Rare

Malattie Genetiche Rare: Testimonianze e News | Telethon - Ricerca Malattie Genetiche Rare

Malattie Genetiche Rare: Testimonianze e News | Telethon Ricerca Malattie Genetiche Rare

Osteopetrosis: new opportunity of treatment thanks to a licensing agreement - Ricerca Malattie Genetiche Rare

Osteopetrosis: new opportunity of treatment thanks to a licensing agreement Ricerca Malattie Genetiche Rare

Alliance between Fondazione Telethon and biopharmaceutical company Shire for research and development of new therapies for rare genetic diseases - Telethon - Ricerca Malattie Genetiche Rare

Alliance between Fondazione Telethon and biopharmaceutical company Shire for research and development of new therapies for rare genetic diseases - Telethon Ricerca Malattie Genetiche Rare

Top Fondazione Telethon Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant